SGP — SpyGlass Pharma, Inc.

—
Nasdaq · Health Care · Health Care Equipment & Supplies · CIK 1778922 ·
Last close
$31.43
Market Cap
$1.05B
52W High
$39.92
52W Low
$17.06
ADV30
103,843
Next earnings
2026-11-12
SpyGlass Pharma, Inc. operates as a biopharmaceutical company that provides treatment and drug delivery for patients living with chronic eye conditions. The company develops the Bimatoprost Drug Pad-IOL System (BIM-IOL System), including novel and proprietary drug pads attached to an intraocular lens (IOL), which is designed to be implanted during routine cataract surgery to reduce elevated intraocular pressure (IOP) in patients. It also develops a non-IOL-based, ring-shaped, sustained-release implant with bimatoprost. SpyGlass Pharma, Inc. was formerly known as SpyGlass Ophthalmics, Inc. and changed its name to SpyGlass Pharma, Inc. in April 2021. The company was headquartered in 2019 and is based in Irvine, California.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Jun 2026 0 — -21,967,000 -19,864,000 243,433,000 223,143,000 11,069,000
Mar 2026 0 — -15,409,000 -13,818,000 258,386,000 238,902,000 8,274,000
Dec 2025 0 — -13,627,711 -12,555,228 115,866,000 96,358,000 214,703,000
Sep 2025 0 — -11,101,289 -9,815,772 127,012,143 106,006,749 214,236,927

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-46,558,000
Investing CF
$-14,178,000
Financing CF
$156,644,000
CapEx
$-3,181,000
Dividends Paid
—
Buybacks
$0
EPS Diluted TTM
$-2.04
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-138,412,000
Inventory
—
Receivables
$678,000
ST Investments
$11,043,000
EBIT TTM
$-62,105,000
Pretax Income TTM
$-56,053,000
Interest Exp TTM
—
Analysts
6

Annual Trend (SEC EDGAR, last 3y)

Revenues vs Net Income (last 3y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 0 -41,449,000 -39,869,000 115,866,000 214,703,000 -98,837,000 -32,701,000
Dec 2024 0 -27,064,000 -29,164,000 23,318,000 83,792,000 -60,474,000 -22,027,000
Dec 2023 0 -14,230,365 -13,318,990 41,149,466 74,134,984 -32,985,518 -12,277,733

TTM Snapshot

Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
$243,433,000
Forward EPS
$-2.98

Peers — same industry

TickerNameMarket CapLastDaily %
IART INTEGRA LIFESCIENCES HOLDINGS CORP $1.05B $13.55 —
SIBN SI-BONE, Inc. $1.04B $23.16 —
ATEC Alphatec Holdings, Inc. $1.06B $6.94 —
IRMD IRADIMED CORP $1.07B $83.45 —
CBLL Ceribell, Inc. $1.01B $25.97 —

News headlines (Yahoo Finance, 1h cache)

SpyGlass Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Updates
2026-11-11 21:05 · Yahoo
SpyGlass Pharma (SGP) Stock Looks Pricey After Its 50% Monthly Jump
2026-11-08 14:09 · Yahoo
SpyGlass Pharma to Participate in Upcoming Investor Conferences
2026-11-05 13:00 · Yahoo
SpyGlass Pharma Announces Positive 4-Year Data From First-in-Human Trial of Its Innovative BIM-IOL System
2026-10-19 12:00 · Yahoo
SpyGlass Pharma Acquires Advanced Vision Science, Inc. (AVS), Securing Scalable Commercial IOL Supply and Accelerating Lens Portfolio Expansion Capability
2026-10-01 12:00 · Yahoo
SpyGlass Pharma Celebrates Grand Opening of New Irvine Headquarters, Positioning Itself for First Product Launch and Custom R&D Space
2026-08-27 20:40 · Yahoo
SpyGlass Pharma Reports First Quarter 2026 Financial Results and Provides Corporate Updates
2026-05-14 20:05 · Yahoo
SpyGlass Pharma Appoints Mike Pinder as Vice President, Marketing
2026-06-02 12:00 · Yahoo
SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System
2026-05-18 12:00 · Yahoo
SpyGlass Pharma (SGP) Jumped, What Is Catching Investors' Attention?
2026-11-08 01:10 · Yahoo

Recent Insider Activity

FiledTradeInsiderTitleType PriceQtyValue
2026-11-18 16:56:12 2026-11-16 Ra Capital Management, L.P. Dir, 10% P - Purchase 32.43 1000 32430